Brief: SMS Pharmaceuticals Completes USFDA Inspection At Central Laboratory Analytical Services
25/06/2025 12:08
June 25 (Reuters) - SMS Pharmaceuticals Ltd SMSP.NS: COMPLETES USFDA INSPECTION AT CENTRAL LABORATORY ANALYTICAL SERVICES USFDA INSPECTION CONCLUDES WITH ZERO FORM 483 OBSERVATIONS Source text: ID:nNSEbttpLK Further company coverage: SMSP.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on SMS Pharmaceuticals
See all newsBrief: SMS Pharmaceuticals Ltd Q2 Consol Net Profit INR 398.5 Million
Brief: SMS Pharmaceuticals March-Quarter Consol Net Profit 327.1 Million Rupees
Brief: Sms Pharmaceuticals Says Tax Demand Reduced To 4 Million Rupees From 71.9 Million Rupees
Advisory: Alert incorrectly tagged to SMS Phramaceuticals withdrawn
Brief: SMS Pharmaceuticals Says Completion Of USFDA Inspection At Vizag Manufacturing Facility